Questioning the transferability of pharmacoeconomic data Meeting report 09 February 2013 Pages: 3 - 3
Few medical interventions bear so small a cost of saving a life as physicians' advice on smoking cessation Review 09 February 2013 Pages: 4 - 4
Preoperative use of leuprorelin* may reduce considerably the costs associated with hysterectomy, Comment 09 February 2013 Pages: 5 - 5
Does type of care system and specialty affect patient outcomes? Clinical study 09 February 2013 Pages: 6 - 6
Two-view should replace one-view mammography in breast cancer screening, Comment 09 February 2013 Pages: 6 - 6
Costs of diagnosing unknown primary carcinoma unwarranted? Clinical study 09 February 2013 Pages: 8 - 8
Economic analysis supports widespread use of rotavirus vaccine Clinical study 09 February 2013 Pages: 8 - 8
Multidisciplinary care for CHF reduces costs and improves QOL Clinical study 09 February 2013 Pages: 8 - 8
Antidepressant therapy has limited impact on resource use Clinical study 09 February 2013 Pages: 9 - 9
Hepatitis B vaccines of half the recommended therapeutic dose are highly immunogenic and cost saving, Volunteers 09 February 2013 Pages: 9 - 9
Computerised DUR and academic detailing reduce drug costs Clinical study 09 February 2013 Pages: 10 - 10
Aminoglycoside audit shows lack of compliance with guidelines Clinical study 09 February 2013 Pages: 11 - 11
Helicobacter pylori eradication should be the treatment of choice for duodenal ulcer, Clinical study 09 February 2013 Pages: 12 - 12
Adolescent hepatitis B vaccination is `economically attractive', Clinical study 09 February 2013 Pages: 12 - 12
Oral fluconazole favoured for antifungal prophylaxis after bone marrow transplantation Clinical study 09 February 2013 Pages: 12 - 12
The antineoplastic regimen etoposide, calcium folinate [leucovorin] and fluorouracil (ELF) is too costly Clinical study 09 February 2013 Pages: 12 - 12
Urokinase is more cost effective than surgery for acute peripheral arterial occlusions, Clinical study 09 February 2013 Pages: 12 - 12
Consider QOL in survivors of life-threatening arrhythmias Clinical study 09 February 2013 Pages: 13 - 13
QOL assessment highlights outcomes of antineoplastic therapy Clinical study 09 February 2013 Pages: 13 - 13
Switching from parenteral cefotaxime to oral cefixime can lead to substantial hospital cost savings, Clinical study 09 February 2013 Pages: 13 - 13
Noncompliance among prescription drug users costs the Canadian healthcare system between $Can7–9 billion News item 09 February 2013 Pages: 15 - 15